Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitochondria | 90 | 2024 | 3600 | 8.290 |
Why?
|
Mitochondrial Diseases | 29 | 2024 | 340 | 6.250 |
Why?
|
DNA, Mitochondrial | 38 | 2024 | 858 | 5.450 |
Why?
|
Calcium Channels | 22 | 2024 | 619 | 5.330 |
Why?
|
Leigh Disease | 15 | 2023 | 89 | 4.390 |
Why?
|
Oxidative Phosphorylation | 26 | 2023 | 495 | 4.310 |
Why?
|
Mitochondrial Proteins | 33 | 2024 | 979 | 4.070 |
Why?
|
Mitochondrial Membrane Transport Proteins | 15 | 2020 | 159 | 3.550 |
Why?
|
Electron Transport Complex I | 15 | 2024 | 152 | 3.460 |
Why?
|
Calcium-Binding Proteins | 14 | 2021 | 1067 | 2.710 |
Why?
|
Cation Transport Proteins | 11 | 2020 | 325 | 2.520 |
Why?
|
Oxygen | 17 | 2024 | 4193 | 2.230 |
Why?
|
Iron-Sulfur Proteins | 4 | 2024 | 83 | 1.960 |
Why?
|
MELAS Syndrome | 4 | 2024 | 56 | 1.920 |
Why?
|
NAD | 10 | 2022 | 609 | 1.920 |
Why?
|
Friedreich Ataxia | 3 | 2024 | 77 | 1.870 |
Why?
|
Calcium | 21 | 2024 | 5725 | 1.780 |
Why?
|
Metabolome | 10 | 2020 | 982 | 1.390 |
Why?
|
NADH, NADPH Oxidoreductases | 4 | 2022 | 93 | 1.320 |
Why?
|
Energy Metabolism | 13 | 2024 | 2869 | 1.310 |
Why?
|
Cytosol | 7 | 2024 | 887 | 1.250 |
Why?
|
NADP | 4 | 2019 | 223 | 1.230 |
Why?
|
K562 Cells | 9 | 2023 | 640 | 1.190 |
Why?
|
Databases, Protein | 5 | 2021 | 388 | 1.180 |
Why?
|
HEK293 Cells | 27 | 2021 | 4264 | 1.160 |
Why?
|
Proteome | 10 | 2023 | 1855 | 1.120 |
Why?
|
Glycolysis | 7 | 2023 | 828 | 1.100 |
Why?
|
Metabolic Networks and Pathways | 6 | 2018 | 789 | 1.090 |
Why?
|
Protein Engineering | 4 | 2020 | 541 | 1.090 |
Why?
|
Meclizine | 4 | 2015 | 13 | 1.050 |
Why?
|
Neurodegenerative Diseases | 5 | 2023 | 1084 | 0.970 |
Why?
|
Mitochondrial Myopathies | 4 | 2020 | 49 | 0.970 |
Why?
|
Genomics | 12 | 2017 | 5794 | 0.910 |
Why?
|
Multienzyme Complexes | 3 | 2020 | 666 | 0.900 |
Why?
|
Ferredoxins | 1 | 2023 | 9 | 0.900 |
Why?
|
Caenorhabditis elegans | 6 | 2024 | 1444 | 0.880 |
Why?
|
HeLa Cells | 14 | 2021 | 3105 | 0.880 |
Why?
|
Genetic Fitness | 1 | 2024 | 115 | 0.850 |
Why?
|
Lyases | 1 | 2022 | 41 | 0.850 |
Why?
|
Oxidation-Reduction | 11 | 2024 | 2222 | 0.850 |
Why?
|
Lipoylation | 1 | 2023 | 88 | 0.830 |
Why?
|
Stress, Physiological | 2 | 2020 | 1398 | 0.830 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2023 | 114 | 0.830 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2022 | 53 | 0.830 |
Why?
|
Polycythemia | 1 | 2023 | 125 | 0.820 |
Why?
|
Protein Biosynthesis | 8 | 2024 | 2105 | 0.820 |
Why?
|
Cell Line | 21 | 2024 | 15620 | 0.780 |
Why?
|
Lactic Acid | 4 | 2024 | 1134 | 0.770 |
Why?
|
Saccharomyces cerevisiae | 8 | 2023 | 2698 | 0.770 |
Why?
|
Gluconeogenesis | 3 | 2024 | 185 | 0.770 |
Why?
|
Oxygen Consumption | 10 | 2022 | 1843 | 0.760 |
Why?
|
Ribonucleoprotein, U1 Small Nuclear | 1 | 2021 | 37 | 0.760 |
Why?
|
Succinates | 2 | 2019 | 81 | 0.760 |
Why?
|
Genome, Mitochondrial | 4 | 2022 | 66 | 0.750 |
Why?
|
Mutation | 29 | 2024 | 29932 | 0.750 |
Why?
|
Electron Transport | 7 | 2017 | 206 | 0.730 |
Why?
|
Electron Transport Chain Complex Proteins | 2 | 2021 | 38 | 0.730 |
Why?
|
Organelles | 2 | 2021 | 267 | 0.720 |
Why?
|
RNA-Binding Proteins | 4 | 2021 | 1894 | 0.700 |
Why?
|
Evolution, Molecular | 5 | 2020 | 1885 | 0.700 |
Why?
|
Vitamin B 12 | 3 | 2024 | 522 | 0.700 |
Why?
|
Mice | 56 | 2024 | 81208 | 0.700 |
Why?
|
Quantitative Trait, Heritable | 2 | 2021 | 540 | 0.690 |
Why?
|
Chlorides | 1 | 2022 | 663 | 0.680 |
Why?
|
RNA Precursors | 1 | 2021 | 212 | 0.680 |
Why?
|
Animals | 84 | 2024 | 167963 | 0.680 |
Why?
|
Cell Nucleus | 6 | 2023 | 2907 | 0.680 |
Why?
|
EF Hand Motifs | 4 | 2019 | 14 | 0.670 |
Why?
|
Catalase | 1 | 2020 | 216 | 0.670 |
Why?
|
Cold-Shock Response | 1 | 2019 | 16 | 0.670 |
Why?
|
Selection, Genetic | 1 | 2024 | 869 | 0.660 |
Why?
|
Genetic Variation | 7 | 2021 | 6551 | 0.650 |
Why?
|
Iron-Binding Proteins | 1 | 2019 | 79 | 0.650 |
Why?
|
Liver | 10 | 2024 | 7509 | 0.640 |
Why?
|
Mammals | 3 | 2023 | 1131 | 0.640 |
Why?
|
Aminohydrolases | 2 | 2019 | 18 | 0.640 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 2 | 2019 | 17 | 0.630 |
Why?
|
Mixed Function Oxygenases | 1 | 2020 | 265 | 0.630 |
Why?
|
Proteomics | 13 | 2020 | 3817 | 0.620 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 524 | 0.620 |
Why?
|
Humans | 153 | 2024 | 760621 | 0.620 |
Why?
|
Carbon-Carbon Lyases | 1 | 2017 | 2 | 0.610 |
Why?
|
Multiprotein Complexes | 4 | 2020 | 1120 | 0.600 |
Why?
|
Glycogen Storage Disease Type V | 1 | 2017 | 8 | 0.590 |
Why?
|
Citric Acid Cycle | 2 | 2024 | 230 | 0.580 |
Why?
|
Sequence Analysis, DNA | 9 | 2022 | 4713 | 0.580 |
Why?
|
Cell Respiration | 10 | 2020 | 202 | 0.580 |
Why?
|
Shock, Septic | 1 | 2024 | 761 | 0.580 |
Why?
|
Hyperoxia | 1 | 2019 | 250 | 0.580 |
Why?
|
Ataxia | 2 | 2023 | 305 | 0.570 |
Why?
|
Neoplasm Proteins | 5 | 2018 | 3610 | 0.560 |
Why?
|
RNA Splicing | 2 | 2021 | 915 | 0.560 |
Why?
|
Carbon | 2 | 2021 | 669 | 0.560 |
Why?
|
DNA Copy Number Variations | 3 | 2023 | 2013 | 0.560 |
Why?
|
Thermogenesis | 2 | 2019 | 468 | 0.560 |
Why?
|
Glutathione | 2 | 2022 | 582 | 0.550 |
Why?
|
Methyltransferases | 4 | 2024 | 374 | 0.550 |
Why?
|
Adenoma, Oxyphilic | 1 | 2018 | 148 | 0.550 |
Why?
|
Naphthoquinones | 1 | 2016 | 60 | 0.550 |
Why?
|
Cell Division | 1 | 2024 | 4463 | 0.540 |
Why?
|
Gene Knockout Techniques | 5 | 2023 | 802 | 0.540 |
Why?
|
Genome | 6 | 2022 | 1739 | 0.540 |
Why?
|
Carbon Monoxide | 1 | 2019 | 540 | 0.530 |
Why?
|
Homeostasis | 12 | 2022 | 3306 | 0.520 |
Why?
|
Glycine | 3 | 2016 | 662 | 0.520 |
Why?
|
Longevity | 1 | 2023 | 1050 | 0.510 |
Why?
|
Manganese | 1 | 2018 | 395 | 0.510 |
Why?
|
Bacteria | 2 | 2020 | 2199 | 0.510 |
Why?
|
Calcium Signaling | 4 | 2015 | 732 | 0.510 |
Why?
|
Folic Acid | 3 | 2021 | 1309 | 0.500 |
Why?
|
Polymorphism, Genetic | 2 | 2020 | 4291 | 0.500 |
Why?
|
Sodium Benzoate | 1 | 2014 | 15 | 0.490 |
Why?
|
Cell Lineage | 1 | 2024 | 2533 | 0.490 |
Why?
|
Heart Rate | 2 | 2024 | 4179 | 0.490 |
Why?
|
Molecular Biology | 1 | 2018 | 580 | 0.480 |
Why?
|
Lipid Metabolism | 4 | 2020 | 1902 | 0.480 |
Why?
|
Adipose Tissue, Brown | 3 | 2019 | 755 | 0.470 |
Why?
|
Muscle, Skeletal | 10 | 2017 | 4925 | 0.470 |
Why?
|
Malate Synthase | 1 | 2013 | 2 | 0.470 |
Why?
|
Gene Expression Profiling | 12 | 2018 | 9411 | 0.470 |
Why?
|
Ethanolamines | 2 | 2015 | 154 | 0.460 |
Why?
|
Oxo-Acid-Lyases | 1 | 2013 | 22 | 0.460 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2016 | 307 | 0.460 |
Why?
|
Phylogeny | 4 | 2014 | 2775 | 0.460 |
Why?
|
Feasibility Studies | 1 | 2024 | 5201 | 0.450 |
Why?
|
Glucose Tolerance Test | 4 | 2020 | 1175 | 0.450 |
Why?
|
Lymphocyte Activation | 2 | 2024 | 5496 | 0.450 |
Why?
|
Glucose | 10 | 2023 | 4351 | 0.440 |
Why?
|
Genes, Mitochondrial | 4 | 2020 | 62 | 0.440 |
Why?
|
RNA, Messenger | 10 | 2021 | 12766 | 0.440 |
Why?
|
Amino Acid Sequence | 15 | 2017 | 13451 | 0.440 |
Why?
|
Models, Biological | 6 | 2017 | 9467 | 0.430 |
Why?
|
Gene Targeting | 3 | 2013 | 839 | 0.430 |
Why?
|
RNA, Transfer, Met | 2 | 2014 | 14 | 0.430 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2380 | 0.420 |
Why?
|
Fibroblasts | 6 | 2024 | 4090 | 0.420 |
Why?
|
Galactose | 4 | 2022 | 297 | 0.420 |
Why?
|
RNA | 3 | 2023 | 2722 | 0.420 |
Why?
|
Disease | 3 | 2013 | 671 | 0.420 |
Why?
|
Methylmalonyl-CoA Mutase | 2 | 2024 | 23 | 0.410 |
Why?
|
High-Throughput Screening Assays | 3 | 2016 | 944 | 0.410 |
Why?
|
Reactive Oxygen Species | 5 | 2020 | 2138 | 0.400 |
Why?
|
Enzymes | 1 | 2013 | 261 | 0.400 |
Why?
|
Wolfram Syndrome | 1 | 2012 | 15 | 0.400 |
Why?
|
Cluster Analysis | 4 | 2017 | 2698 | 0.400 |
Why?
|
Cyclooxygenase 1 | 1 | 2011 | 97 | 0.380 |
Why?
|
Eukaryota | 1 | 2012 | 100 | 0.380 |
Why?
|
Myoblasts | 4 | 2020 | 232 | 0.380 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2014 | 415 | 0.370 |
Why?
|
Sirolimus | 3 | 2017 | 1547 | 0.370 |
Why?
|
Cell Hypoxia | 3 | 2023 | 658 | 0.370 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2299 | 0.360 |
Why?
|
Disease Models, Animal | 12 | 2023 | 18137 | 0.360 |
Why?
|
Gene Knockdown Techniques | 7 | 2021 | 1617 | 0.360 |
Why?
|
Gene Expression Regulation | 13 | 2021 | 11903 | 0.360 |
Why?
|
Culture Media | 4 | 2023 | 900 | 0.350 |
Why?
|
Molecular Sequence Data | 15 | 2015 | 17624 | 0.350 |
Why?
|
Mitochondrial Membranes | 5 | 2021 | 172 | 0.350 |
Why?
|
Cell Size | 1 | 2012 | 624 | 0.350 |
Why?
|
Thoracoscopy | 1 | 2011 | 176 | 0.350 |
Why?
|
Sepsis | 1 | 2024 | 2592 | 0.340 |
Why?
|
Muscular Diseases | 2 | 2011 | 551 | 0.340 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 961 | 0.340 |
Why?
|
Neuraminidase | 1 | 2010 | 200 | 0.330 |
Why?
|
Intracellular Membranes | 5 | 2017 | 389 | 0.330 |
Why?
|
Trans-Activators | 10 | 2021 | 2860 | 0.330 |
Why?
|
Protein Stability | 3 | 2023 | 566 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3616 | 0.320 |
Why?
|
Muscle Cells | 1 | 2010 | 195 | 0.320 |
Why?
|
Activating Transcription Factor 4 | 2 | 2019 | 82 | 0.320 |
Why?
|
Glycogen | 2 | 2021 | 251 | 0.320 |
Why?
|
Growth Differentiation Factor 15 | 2 | 2021 | 196 | 0.310 |
Why?
|
Ion Transport | 4 | 2020 | 318 | 0.310 |
Why?
|
Software | 3 | 2021 | 4419 | 0.300 |
Why?
|
Genome-Wide Association Study | 9 | 2023 | 12626 | 0.300 |
Why?
|
Base Sequence | 13 | 2020 | 12446 | 0.300 |
Why?
|
Glucose Intolerance | 3 | 2008 | 580 | 0.300 |
Why?
|
5' Untranslated Regions | 1 | 2009 | 256 | 0.290 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2014 | 781 | 0.290 |
Why?
|
Pleural Effusion | 1 | 2011 | 342 | 0.290 |
Why?
|
Blood Glucose | 5 | 2014 | 6381 | 0.290 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4319 | 0.290 |
Why?
|
Heme | 1 | 2009 | 313 | 0.290 |
Why?
|
Lipolysis | 2 | 2024 | 211 | 0.290 |
Why?
|
Cryoelectron Microscopy | 2 | 2024 | 642 | 0.290 |
Why?
|
Cell Death | 3 | 2019 | 1672 | 0.290 |
Why?
|
Biological Products | 1 | 2016 | 916 | 0.280 |
Why?
|
Respiration | 4 | 2024 | 1654 | 0.280 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2019 | 193 | 0.280 |
Why?
|
Insulin | 8 | 2015 | 6597 | 0.280 |
Why?
|
Models, Molecular | 8 | 2020 | 5434 | 0.270 |
Why?
|
Male | 56 | 2024 | 359744 | 0.270 |
Why?
|
Abnormalities, Multiple | 1 | 2014 | 1415 | 0.270 |
Why?
|
Coenzyme A | 2 | 2019 | 40 | 0.270 |
Why?
|
Propionates | 2 | 2024 | 182 | 0.270 |
Why?
|
Phenotype | 9 | 2018 | 16546 | 0.260 |
Why?
|
Protein Structure, Tertiary | 5 | 2016 | 3800 | 0.260 |
Why?
|
Aging | 2 | 2023 | 8651 | 0.260 |
Why?
|
Open Reading Frames | 1 | 2009 | 814 | 0.260 |
Why?
|
RNA Interference | 6 | 2014 | 2846 | 0.260 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 2012 | 436 | 0.250 |
Why?
|
Mass Spectrometry | 6 | 2021 | 2192 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2009 | 3775 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2013 | 2058 | 0.250 |
Why?
|
DNA Mutational Analysis | 4 | 2012 | 4107 | 0.250 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2024 | 866 | 0.240 |
Why?
|
N-Formylmethionine | 1 | 2024 | 14 | 0.240 |
Why?
|
RNA, Transfer, Leu | 1 | 2024 | 13 | 0.240 |
Why?
|
Genetic Association Studies | 2 | 2012 | 2717 | 0.240 |
Why?
|
Cell Membrane | 2 | 2013 | 3682 | 0.230 |
Why?
|
Insulin Resistance | 4 | 2020 | 3959 | 0.230 |
Why?
|
Cytochrome c Group | 2 | 2001 | 122 | 0.230 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2017 | 296 | 0.230 |
Why?
|
Oxidoreductases | 3 | 2022 | 412 | 0.230 |
Why?
|
Sulfurtransferases | 1 | 2023 | 17 | 0.230 |
Why?
|
Fibroblast Growth Factors | 2 | 2020 | 869 | 0.220 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2024 | 173 | 0.220 |
Why?
|
Huntington Disease | 1 | 2010 | 1141 | 0.220 |
Why?
|
Lipid Peroxides | 1 | 2023 | 74 | 0.220 |
Why?
|
Binding Sites | 4 | 2023 | 6048 | 0.220 |
Why?
|
Hydroxymethyl and Formyl Transferases | 2 | 2014 | 18 | 0.220 |
Why?
|
Carrier Proteins | 5 | 2017 | 4938 | 0.220 |
Why?
|
Thioctic Acid | 1 | 2023 | 28 | 0.220 |
Why?
|
Glucokinase | 1 | 2023 | 102 | 0.220 |
Why?
|
Ribose | 1 | 2023 | 63 | 0.220 |
Why?
|
Respiratory Rate | 1 | 2024 | 175 | 0.220 |
Why?
|
Cytochrome-c Oxidase Deficiency | 1 | 2003 | 14 | 0.220 |
Why?
|
Pentose Phosphate Pathway | 2 | 2023 | 126 | 0.220 |
Why?
|
Cardiomyopathies | 3 | 2020 | 1952 | 0.220 |
Why?
|
Oxyphil Cells | 1 | 2023 | 57 | 0.220 |
Why?
|
Enzyme Inhibitors | 2 | 2013 | 3726 | 0.210 |
Why?
|
Fermentation | 1 | 2023 | 146 | 0.210 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2020 | 542 | 0.210 |
Why?
|
Rubredoxins | 1 | 2022 | 2 | 0.210 |
Why?
|
Uridine | 1 | 2023 | 143 | 0.210 |
Why?
|
Cyclophilins | 1 | 2022 | 47 | 0.210 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10181 | 0.210 |
Why?
|
Allergens | 1 | 2010 | 1402 | 0.210 |
Why?
|
Cell Proliferation | 4 | 2023 | 10446 | 0.210 |
Why?
|
Prediabetic State | 1 | 2008 | 550 | 0.200 |
Why?
|
INDEL Mutation | 1 | 2023 | 266 | 0.200 |
Why?
|
Sequence Deletion | 2 | 2019 | 1493 | 0.200 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2803 | 0.200 |
Why?
|
Membrane Proteins | 9 | 2020 | 7850 | 0.200 |
Why?
|
Cytochromes b | 1 | 2021 | 34 | 0.200 |
Why?
|
Cytidine Deaminase | 2 | 2022 | 245 | 0.200 |
Why?
|
Female | 43 | 2024 | 391270 | 0.200 |
Why?
|
Trichomonas vaginalis | 1 | 2022 | 70 | 0.200 |
Why?
|
Drug Discovery | 1 | 2010 | 1057 | 0.200 |
Why?
|
Phosphofructokinase-1, Muscle Type | 1 | 2021 | 4 | 0.190 |
Why?
|
Databases, Factual | 1 | 2017 | 8035 | 0.190 |
Why?
|
Methionine | 1 | 2024 | 569 | 0.190 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4312 | 0.190 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2024 | 404 | 0.190 |
Why?
|
Cardiolipins | 2 | 2020 | 81 | 0.190 |
Why?
|
Amino Acid Transport System y+ | 1 | 2021 | 37 | 0.190 |
Why?
|
Metabolomics | 3 | 2024 | 1628 | 0.190 |
Why?
|
Transcription Factors | 12 | 2023 | 12103 | 0.190 |
Why?
|
Chromatography, Liquid | 4 | 2017 | 987 | 0.190 |
Why?
|
Mice, Knockout | 10 | 2024 | 14372 | 0.190 |
Why?
|
Triglycerides | 2 | 2020 | 2476 | 0.180 |
Why?
|
Mice, Inbred C57BL | 13 | 2024 | 22023 | 0.180 |
Why?
|
Computational Biology | 4 | 2010 | 3505 | 0.180 |
Why?
|
Hydroxybutyrates | 1 | 2021 | 79 | 0.180 |
Why?
|
Twins, Monozygotic | 1 | 2022 | 469 | 0.180 |
Why?
|
Mitochondria, Liver | 3 | 2024 | 190 | 0.180 |
Why?
|
Exercise | 1 | 2017 | 5787 | 0.180 |
Why?
|
Cell Line, Transformed | 2 | 2014 | 869 | 0.180 |
Why?
|
Diseases in Twins | 1 | 2022 | 447 | 0.180 |
Why?
|
G-Quadruplexes | 1 | 2023 | 190 | 0.180 |
Why?
|
Anaerobiosis | 2 | 2021 | 139 | 0.180 |
Why?
|
Receptors, Estrogen | 2 | 2010 | 2210 | 0.180 |
Why?
|
Alanine | 2 | 2021 | 606 | 0.180 |
Why?
|
Bayes Theorem | 2 | 2021 | 2326 | 0.180 |
Why?
|
Iron | 3 | 2022 | 1786 | 0.180 |
Why?
|
Asparagine | 1 | 2020 | 119 | 0.180 |
Why?
|
Oligomycins | 1 | 2019 | 20 | 0.180 |
Why?
|
Neuroendocrine Cells | 1 | 2021 | 62 | 0.170 |
Why?
|
Adult | 20 | 2024 | 219994 | 0.170 |
Why?
|
Mitochondrial Encephalomyopathies | 3 | 2017 | 40 | 0.170 |
Why?
|
Ribosomal Proteins | 2 | 2023 | 363 | 0.170 |
Why?
|
Homozygote | 6 | 2019 | 1788 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 854 | 0.170 |
Why?
|
Iron Regulatory Protein 2 | 1 | 2019 | 42 | 0.170 |
Why?
|
Burkitt Lymphoma | 1 | 2021 | 333 | 0.170 |
Why?
|
Protein Conformation | 4 | 2020 | 3969 | 0.160 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2020 | 1854 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2011 | 3334 | 0.160 |
Why?
|
Pyruvic Acid | 1 | 2020 | 195 | 0.160 |
Why?
|
Neosartorya | 1 | 2018 | 1 | 0.160 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 1173 | 0.160 |
Why?
|
Adenosine Triphosphate | 3 | 2022 | 1993 | 0.160 |
Why?
|
Bacterial Proteins | 3 | 2020 | 3826 | 0.160 |
Why?
|
Sulfur | 1 | 2019 | 163 | 0.160 |
Why?
|
Dictyostelium | 2 | 2020 | 70 | 0.160 |
Why?
|
Mitochondria, Heart | 3 | 2015 | 229 | 0.160 |
Why?
|
Glutathione Peroxidase | 1 | 2019 | 256 | 0.160 |
Why?
|
Protein Transport | 4 | 2013 | 1964 | 0.160 |
Why?
|
Influenza, Human | 1 | 2010 | 1528 | 0.160 |
Why?
|
Brain | 4 | 2021 | 26951 | 0.160 |
Why?
|
Insulin-Secreting Cells | 2 | 2021 | 907 | 0.160 |
Why?
|
Tandem Mass Spectrometry | 4 | 2017 | 1189 | 0.150 |
Why?
|
Endoplasmic Reticulum | 2 | 2017 | 1132 | 0.150 |
Why?
|
Zebrafish | 4 | 2016 | 2997 | 0.150 |
Why?
|
Cells, Cultured | 9 | 2017 | 18957 | 0.150 |
Why?
|
Pheochromocytoma | 1 | 2000 | 328 | 0.150 |
Why?
|
Multigene Family | 2 | 2013 | 1077 | 0.150 |
Why?
|
Ribosome Subunits, Small, Eukaryotic | 1 | 2017 | 17 | 0.150 |
Why?
|
Gene Dosage | 2 | 2014 | 1218 | 0.150 |
Why?
|
Amino Acids | 1 | 2024 | 1714 | 0.150 |
Why?
|
Cell Transformation, Viral | 1 | 2019 | 526 | 0.150 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2004 | 1112 | 0.150 |
Why?
|
Genetic Complementation Test | 2 | 2016 | 555 | 0.150 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2017 | 63 | 0.150 |
Why?
|
Algorithms | 2 | 2017 | 13981 | 0.150 |
Why?
|
Epistasis, Genetic | 1 | 2019 | 350 | 0.150 |
Why?
|
Amino Acid Motifs | 2 | 2017 | 929 | 0.140 |
Why?
|
Oxidative Stress | 2 | 2019 | 3106 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2012 | 12293 | 0.140 |
Why?
|
Herpesvirus 4, Human | 2 | 2021 | 1075 | 0.140 |
Why?
|
Antiviral Agents | 1 | 2010 | 3061 | 0.140 |
Why?
|
Proteins | 6 | 2018 | 6029 | 0.140 |
Why?
|
Bignoniaceae | 1 | 2016 | 4 | 0.140 |
Why?
|
Ericaceae | 1 | 2016 | 4 | 0.140 |
Why?
|
Smegmamorpha | 1 | 2016 | 12 | 0.140 |
Why?
|
Ribonucleoproteins | 1 | 2019 | 372 | 0.140 |
Why?
|
Internet | 3 | 2021 | 3078 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2021 | 608 | 0.140 |
Why?
|
Biotin | 1 | 2017 | 253 | 0.140 |
Why?
|
Onium Compounds | 1 | 1996 | 27 | 0.140 |
Why?
|
Thyroid Gland | 1 | 2023 | 1168 | 0.140 |
Why?
|
Antimycin A | 1 | 2016 | 31 | 0.140 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2019 | 376 | 0.130 |
Why?
|
Cyclin D1 | 1 | 2018 | 451 | 0.130 |
Why?
|
Lysosomes | 1 | 2021 | 920 | 0.130 |
Why?
|
Diamines | 1 | 1996 | 59 | 0.130 |
Why?
|
Lipids | 2 | 2020 | 3336 | 0.130 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 635 | 0.130 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2017 | 1006 | 0.130 |
Why?
|
Pedigree | 5 | 2020 | 4578 | 0.130 |
Why?
|
Heterozygote | 2 | 2014 | 2798 | 0.130 |
Why?
|
Vasoconstriction | 1 | 2018 | 593 | 0.130 |
Why?
|
Suppression, Genetic | 1 | 2016 | 190 | 0.130 |
Why?
|
Ion Channels | 5 | 2015 | 1043 | 0.130 |
Why?
|
Anemia | 2 | 2019 | 1511 | 0.130 |
Why?
|
Drosophila | 1 | 2023 | 1492 | 0.130 |
Why?
|
Glutamic Acid | 1 | 2021 | 1167 | 0.130 |
Why?
|
Autoantigens | 1 | 2019 | 877 | 0.130 |
Why?
|
Substrate Specificity | 3 | 2020 | 1792 | 0.130 |
Why?
|
Molecular Structure | 2 | 2011 | 1895 | 0.120 |
Why?
|
Hippurates | 1 | 2014 | 16 | 0.120 |
Why?
|
Food Preservatives | 1 | 2014 | 11 | 0.120 |
Why?
|
Organophosphorus Compounds | 1 | 1996 | 202 | 0.120 |
Why?
|
Microelectrodes | 1 | 1996 | 304 | 0.120 |
Why?
|
Conserved Sequence | 2 | 2017 | 1167 | 0.120 |
Why?
|
Ischemic Preconditioning | 1 | 2015 | 89 | 0.120 |
Why?
|
Rhodophyta | 1 | 2014 | 10 | 0.120 |
Why?
|
Trachea | 1 | 2021 | 1082 | 0.120 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2000 | 733 | 0.120 |
Why?
|
Cell Survival | 2 | 2018 | 5797 | 0.120 |
Why?
|
Bacterial Toxins | 1 | 2020 | 931 | 0.120 |
Why?
|
RNA, Small Interfering | 3 | 2014 | 3442 | 0.120 |
Why?
|
Membrane Transport Proteins | 4 | 2022 | 1035 | 0.120 |
Why?
|
Alleles | 2 | 2023 | 6898 | 0.120 |
Why?
|
Animal Structures | 1 | 2014 | 24 | 0.120 |
Why?
|
Protective Agents | 1 | 2015 | 150 | 0.120 |
Why?
|
Isoquinolines | 1 | 2016 | 353 | 0.120 |
Why?
|
Catalysis | 1 | 2016 | 775 | 0.120 |
Why?
|
Glyoxylates | 1 | 2013 | 11 | 0.120 |
Why?
|
Azoospermia | 1 | 2014 | 28 | 0.120 |
Why?
|
DNA-Binding Proteins | 5 | 2007 | 9585 | 0.110 |
Why?
|
Malates | 1 | 2013 | 34 | 0.110 |
Why?
|
Acyl Coenzyme A | 1 | 2013 | 57 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 8515 | 0.110 |
Why?
|
Membrane Potentials | 4 | 2010 | 1095 | 0.110 |
Why?
|
Neoplasms | 2 | 2014 | 22072 | 0.110 |
Why?
|
Body Temperature | 2 | 2016 | 777 | 0.110 |
Why?
|
Acetyl Coenzyme A | 1 | 2013 | 75 | 0.110 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2013 | 62 | 0.110 |
Why?
|
Anemia, Macrocytic | 1 | 2013 | 54 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2023 | 2895 | 0.110 |
Why?
|
Iron-Regulatory Proteins | 1 | 2013 | 30 | 0.110 |
Why?
|
Adolescent | 12 | 2021 | 87810 | 0.110 |
Why?
|
DNA Primers | 3 | 2013 | 2819 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1827 | 0.110 |
Why?
|
Sequence Alignment | 3 | 2013 | 2176 | 0.110 |
Why?
|
RNA, Complementary | 1 | 2013 | 45 | 0.110 |
Why?
|
Yeasts | 1 | 2014 | 279 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1139 | 0.110 |
Why?
|
Riboflavin | 1 | 2013 | 105 | 0.110 |
Why?
|
Endonucleases | 1 | 2016 | 370 | 0.110 |
Why?
|
Microscopy, Electron | 2 | 2016 | 2558 | 0.110 |
Why?
|
Child, Preschool | 8 | 2021 | 42063 | 0.110 |
Why?
|
Virus Replication | 1 | 2021 | 2432 | 0.110 |
Why?
|
Nuclear Proteins | 3 | 2017 | 5791 | 0.110 |
Why?
|
Feedback, Physiological | 1 | 2015 | 476 | 0.110 |
Why?
|
Middle Aged | 15 | 2021 | 220352 | 0.110 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2012 | 264 | 0.110 |
Why?
|
DNA, Neoplasm | 1 | 2018 | 1745 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1407 | 0.100 |
Why?
|
Reproducibility of Results | 5 | 2016 | 20080 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 697 | 0.100 |
Why?
|
Signal Transduction | 5 | 2020 | 23376 | 0.100 |
Why?
|
Apoptosis | 3 | 2019 | 9501 | 0.100 |
Why?
|
Glucagon | 1 | 2014 | 532 | 0.100 |
Why?
|
Child | 12 | 2021 | 79806 | 0.100 |
Why?
|
Peptides | 2 | 2017 | 4354 | 0.100 |
Why?
|
Glucose Clamp Technique | 3 | 2007 | 263 | 0.100 |
Why?
|
Pantothenate Kinase-Associated Neurodegeneration | 1 | 2011 | 13 | 0.100 |
Why?
|
Immunoblotting | 2 | 2014 | 1649 | 0.100 |
Why?
|
Neuroaxonal Dystrophies | 1 | 2011 | 26 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2020 | 3735 | 0.100 |
Why?
|
Biological Evolution | 2 | 2020 | 1074 | 0.100 |
Why?
|
Antiemetics | 1 | 2013 | 187 | 0.100 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2023 | 15789 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1764 | 0.100 |
Why?
|
Biotinylation | 3 | 2017 | 184 | 0.100 |
Why?
|
Lentivirus | 2 | 2011 | 506 | 0.100 |
Why?
|
Exodeoxyribonucleases | 1 | 2013 | 195 | 0.100 |
Why?
|
Genetic Techniques | 1 | 2014 | 428 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4353 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2021 | 11481 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1347 | 0.090 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 2010 | 31 | 0.090 |
Why?
|
Child Nutrition Disorders | 1 | 2012 | 150 | 0.090 |
Why?
|
Research | 1 | 2019 | 1974 | 0.090 |
Why?
|
TRPV Cation Channels | 1 | 2012 | 243 | 0.090 |
Why?
|
Obesity | 5 | 2019 | 12922 | 0.090 |
Why?
|
Kidney | 2 | 2017 | 7064 | 0.090 |
Why?
|
Hexoses | 1 | 2010 | 29 | 0.090 |
Why?
|
Serine | 3 | 2021 | 830 | 0.090 |
Why?
|
Zanamivir | 1 | 2010 | 21 | 0.090 |
Why?
|
Antigens, Plant | 1 | 2010 | 104 | 0.090 |
Why?
|
Genes, Reporter | 2 | 2012 | 1529 | 0.090 |
Why?
|
Protein Structure, Quaternary | 1 | 2011 | 428 | 0.090 |
Why?
|
Gene Deletion | 2 | 2021 | 2668 | 0.090 |
Why?
|
Causality | 2 | 2013 | 1242 | 0.090 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1974 | 0.090 |
Why?
|
Carbazoles | 1 | 2011 | 220 | 0.090 |
Why?
|
Glycosphingolipids | 1 | 2010 | 73 | 0.080 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 819 | 0.080 |
Why?
|
Sulfonamides | 1 | 2019 | 1977 | 0.080 |
Why?
|
Genome, Human | 2 | 2018 | 4417 | 0.080 |
Why?
|
B-Lymphocytes | 2 | 2021 | 4742 | 0.080 |
Why?
|
Oseltamivir | 1 | 2010 | 76 | 0.080 |
Why?
|
Transcription, Genetic | 6 | 2021 | 7593 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.080 |
Why?
|
Virion | 1 | 2011 | 421 | 0.080 |
Why?
|
Mutant Proteins | 1 | 2011 | 492 | 0.080 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 16939 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2015 | 22053 | 0.080 |
Why?
|
Electron Transport Complex IV | 3 | 2004 | 190 | 0.080 |
Why?
|
Young Adult | 6 | 2017 | 58741 | 0.080 |
Why?
|
Molecular Weight | 1 | 2011 | 2186 | 0.080 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2014 | 611 | 0.080 |
Why?
|
Prostaglandins | 1 | 2010 | 398 | 0.080 |
Why?
|
COS Cells | 3 | 2017 | 1129 | 0.080 |
Why?
|
Purines | 1 | 2012 | 605 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2014 | 2061 | 0.080 |
Why?
|
Reperfusion Injury | 1 | 2015 | 1023 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1741 | 0.080 |
Why?
|
Transduction, Genetic | 1 | 2011 | 897 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 1903 | 0.080 |
Why?
|
Fasting | 3 | 2012 | 1603 | 0.080 |
Why?
|
Myocardium | 3 | 2000 | 4700 | 0.080 |
Why?
|
Mutation, Missense | 4 | 2012 | 2566 | 0.080 |
Why?
|
Propranolol | 1 | 2010 | 489 | 0.080 |
Why?
|
Organ Specificity | 3 | 2008 | 1955 | 0.080 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2019 | 1628 | 0.080 |
Why?
|
Body Weight | 3 | 2016 | 4611 | 0.080 |
Why?
|
Aged | 10 | 2023 | 169152 | 0.070 |
Why?
|
Exons | 2 | 2012 | 2388 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2007 | 6068 | 0.070 |
Why?
|
India | 2 | 2013 | 2336 | 0.070 |
Why?
|
Stem Cells | 1 | 2021 | 3523 | 0.070 |
Why?
|
YY1 Transcription Factor | 1 | 2007 | 59 | 0.070 |
Why?
|
Creatine | 1 | 2010 | 426 | 0.070 |
Why?
|
Qb-SNARE Proteins | 1 | 2007 | 34 | 0.070 |
Why?
|
Tubulin Modulators | 1 | 2008 | 107 | 0.070 |
Why?
|
Ketones | 1 | 2008 | 183 | 0.070 |
Why?
|
Mathematics | 1 | 2008 | 707 | 0.070 |
Why?
|
Blotting, Western | 2 | 2014 | 5039 | 0.070 |
Why?
|
Infant | 6 | 2020 | 36060 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3531 | 0.070 |
Why?
|
GA-Binding Protein Transcription Factor | 2 | 2004 | 43 | 0.070 |
Why?
|
Gene Silencing | 2 | 2010 | 1513 | 0.070 |
Why?
|
Atrophy | 1 | 2012 | 1627 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2007 | 191 | 0.070 |
Why?
|
Heart Injuries | 1 | 2008 | 208 | 0.070 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 734 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2007 | 5785 | 0.070 |
Why?
|
Infant, Newborn | 4 | 2017 | 26181 | 0.070 |
Why?
|
Mice, Mutant Strains | 2 | 2021 | 1753 | 0.070 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 900 | 0.070 |
Why?
|
Molecular Chaperones | 1 | 2010 | 752 | 0.060 |
Why?
|
DNA Replication | 1 | 2013 | 1412 | 0.060 |
Why?
|
Cytoplasm | 1 | 2010 | 1516 | 0.060 |
Why?
|
Gene Expression | 3 | 2020 | 7588 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2012 | 818 | 0.060 |
Why?
|
Science | 1 | 2008 | 239 | 0.060 |
Why?
|
Protein Subunits | 2 | 2019 | 943 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15840 | 0.060 |
Why?
|
Protein Array Analysis | 1 | 2007 | 401 | 0.060 |
Why?
|
Multifactorial Inheritance | 1 | 2013 | 1365 | 0.060 |
Why?
|
Peptide Hydrolases | 1 | 2008 | 623 | 0.060 |
Why?
|
Spinocerebellar Degenerations | 1 | 2005 | 44 | 0.060 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2332 | 0.060 |
Why?
|
MERRF Syndrome | 1 | 2004 | 4 | 0.060 |
Why?
|
RNA, Transfer, Phe | 1 | 2004 | 6 | 0.060 |
Why?
|
Protein Multimerization | 2 | 2020 | 983 | 0.060 |
Why?
|
Anticonvulsants | 1 | 2014 | 1879 | 0.060 |
Why?
|
Adipocytes | 2 | 2012 | 1179 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1846 | 0.060 |
Why?
|
NADH Dehydrogenase | 1 | 2024 | 46 | 0.060 |
Why?
|
Crystallography, X-Ray | 2 | 2019 | 1982 | 0.060 |
Why?
|
Hyperkinesis | 1 | 2004 | 89 | 0.060 |
Why?
|
Plasmodium falciparum | 1 | 2014 | 1742 | 0.060 |
Why?
|
Hypoalbuminemia | 1 | 2005 | 87 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2010 | 1259 | 0.060 |
Why?
|
Kinetics | 2 | 2008 | 6377 | 0.060 |
Why?
|
Cell Cycle | 1 | 2012 | 2934 | 0.060 |
Why?
|
DNA Fingerprinting | 1 | 2003 | 111 | 0.060 |
Why?
|
Ubiquinone | 1 | 2005 | 183 | 0.060 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 621 | 0.050 |
Why?
|
Overweight | 1 | 2014 | 2421 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.050 |
Why?
|
Flavins | 1 | 2022 | 18 | 0.050 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2057 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2005 | 514 | 0.050 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2013 | 1463 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2828 | 0.050 |
Why?
|
FMN Reductase | 1 | 2021 | 13 | 0.050 |
Why?
|
Microtubules | 1 | 2008 | 1072 | 0.050 |
Why?
|
Linkage Disequilibrium | 1 | 2007 | 1996 | 0.050 |
Why?
|
Rats | 6 | 2021 | 23711 | 0.050 |
Why?
|
Mitochondria, Muscle | 2 | 2000 | 172 | 0.050 |
Why?
|
Myocytes, Cardiac | 3 | 2017 | 1657 | 0.050 |
Why?
|
Drosophila melanogaster | 1 | 2010 | 1710 | 0.050 |
Why?
|
Calcitonin Receptor-Like Protein | 1 | 2021 | 7 | 0.050 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2021 | 151 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58995 | 0.050 |
Why?
|
Folic Acid Antagonists | 1 | 2021 | 75 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2651 | 0.050 |
Why?
|
Codon, Nonsense | 2 | 2013 | 281 | 0.050 |
Why?
|
Burkholderia cenocepacia | 1 | 2020 | 3 | 0.050 |
Why?
|
tRNA Methyltransferases | 1 | 2020 | 52 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 17790 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2006 | 2381 | 0.040 |
Why?
|
Protein Kinases | 1 | 2007 | 1612 | 0.040 |
Why?
|
Protein Binding | 1 | 2013 | 9335 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2414 | 0.040 |
Why?
|
Cytidine | 1 | 2020 | 65 | 0.040 |
Why?
|
Barth Syndrome | 1 | 2020 | 25 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1653 | 0.040 |
Why?
|
Deoxyadenosines | 1 | 2019 | 27 | 0.040 |
Why?
|
Cachexia | 1 | 2001 | 198 | 0.040 |
Why?
|
Vero Cells | 1 | 2021 | 482 | 0.040 |
Why?
|
Amino Acid Substitution | 3 | 2014 | 1737 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2005 | 601 | 0.040 |
Why?
|
Proton-Translocating ATPases | 1 | 2000 | 113 | 0.040 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2019 | 162 | 0.040 |
Why?
|
3-Iodobenzylguanidine | 1 | 2000 | 114 | 0.040 |
Why?
|
Swine | 4 | 2015 | 5899 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2802 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 2008 | 1091 | 0.040 |
Why?
|
Metabolic Diseases | 1 | 2006 | 686 | 0.040 |
Why?
|
Hydrogen Bonding | 1 | 2019 | 291 | 0.040 |
Why?
|
Quadriceps Muscle | 1 | 2020 | 154 | 0.040 |
Why?
|
Biocatalysis | 1 | 2019 | 172 | 0.040 |
Why?
|
Cohort Studies | 5 | 2017 | 41335 | 0.040 |
Why?
|
Ruthenium Compounds | 1 | 2018 | 8 | 0.040 |
Why?
|
Pyruvate Dehydrogenase Complex | 1 | 2019 | 63 | 0.040 |
Why?
|
Models, Genetic | 2 | 2008 | 3442 | 0.040 |
Why?
|
Point Mutation | 3 | 2013 | 1594 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11712 | 0.040 |
Why?
|
Epstein-Barr Virus Nuclear Antigens | 1 | 2019 | 157 | 0.040 |
Why?
|
Transfection | 2 | 2004 | 5781 | 0.040 |
Why?
|
Haploidy | 1 | 2018 | 133 | 0.040 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2021 | 314 | 0.040 |
Why?
|
Angiotensin Amide | 1 | 2017 | 4 | 0.040 |
Why?
|
Lysine | 1 | 2022 | 1001 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2005 | 1738 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4407 | 0.040 |
Why?
|
Streptavidin | 1 | 2017 | 82 | 0.040 |
Why?
|
Adrenal Glands | 1 | 2000 | 554 | 0.040 |
Why?
|
Sequence Homology | 1 | 2017 | 195 | 0.040 |
Why?
|
Liver Diseases | 1 | 2006 | 1302 | 0.040 |
Why?
|
Thymidine Kinase | 1 | 2017 | 286 | 0.040 |
Why?
|
Dimerization | 1 | 2019 | 891 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2019 | 706 | 0.040 |
Why?
|
Dogs | 2 | 2005 | 3841 | 0.040 |
Why?
|
RNA, Ribosomal | 1 | 2017 | 226 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1246 | 0.030 |
Why?
|
Cell Count | 1 | 2021 | 1835 | 0.030 |
Why?
|
Iodine Radioisotopes | 1 | 2000 | 1032 | 0.030 |
Why?
|
Syndrome | 2 | 2017 | 3280 | 0.030 |
Why?
|
Solubility | 1 | 2018 | 1088 | 0.030 |
Why?
|
Diet | 1 | 2014 | 8010 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1289 | 0.030 |
Why?
|
Phospholipids | 1 | 2020 | 789 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12965 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2017 | 419 | 0.030 |
Why?
|
Colon | 1 | 2024 | 1788 | 0.030 |
Why?
|
Titrimetry | 1 | 2015 | 35 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2000 | 1975 | 0.030 |
Why?
|
Ion Channel Gating | 1 | 2018 | 436 | 0.030 |
Why?
|
Myoglobin | 1 | 1996 | 159 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1996 | 311 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2017 | 736 | 0.030 |
Why?
|
Sodium Cyanide | 1 | 2015 | 9 | 0.030 |
Why?
|
Down-Regulation | 1 | 2003 | 2913 | 0.030 |
Why?
|
Pulmonary Circulation | 1 | 2018 | 743 | 0.030 |
Why?
|
Water | 1 | 2022 | 1407 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 1997 | 429 | 0.030 |
Why?
|
Heart Failure | 1 | 2020 | 11847 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1229 | 0.030 |
Why?
|
Biological Transport | 1 | 2020 | 2086 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2001 | 3602 | 0.030 |
Why?
|
LLC-PK1 Cells | 1 | 2015 | 125 | 0.030 |
Why?
|
Biotechnology | 1 | 2017 | 281 | 0.030 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 372 | 0.030 |
Why?
|
Cytochromes c | 1 | 2015 | 173 | 0.030 |
Why?
|
Gene Frequency | 1 | 2022 | 3615 | 0.030 |
Why?
|
Deoxyglucose | 1 | 2015 | 333 | 0.030 |
Why?
|
Aorta, Abdominal | 1 | 2017 | 625 | 0.030 |
Why?
|
Bronchi | 1 | 2018 | 848 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 5251 | 0.030 |
Why?
|
Angiotensin II | 1 | 2017 | 849 | 0.030 |
Why?
|
Muscles | 2 | 2013 | 1581 | 0.030 |
Why?
|
Molecular Probes | 1 | 1996 | 313 | 0.030 |
Why?
|
Genetic Pleiotropy | 1 | 2015 | 181 | 0.030 |
Why?
|
Testosterone | 1 | 2005 | 2470 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 2013 | 4169 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2015 | 412 | 0.030 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3150 | 0.030 |
Why?
|
Methotrexate | 1 | 2021 | 1719 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1180 | 0.030 |
Why?
|
Amines | 1 | 2015 | 281 | 0.030 |
Why?
|
Cell Fractionation | 1 | 2014 | 251 | 0.030 |
Why?
|
Peroxidase | 1 | 2017 | 605 | 0.030 |
Why?
|
N-Ethylmaleimide-Sensitive Proteins | 1 | 2013 | 9 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 995 | 0.030 |
Why?
|
Directed Molecular Evolution | 1 | 2014 | 158 | 0.030 |
Why?
|
Viral Proteins | 1 | 2021 | 1802 | 0.030 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 346 | 0.030 |
Why?
|
Gene Components | 1 | 2013 | 27 | 0.030 |
Why?
|
Neurons | 2 | 2010 | 9426 | 0.030 |
Why?
|
Kidney Tubules | 1 | 2015 | 449 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 2015 | 286 | 0.030 |
Why?
|
Puerto Rico | 1 | 2014 | 373 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 511 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1089 | 0.030 |
Why?
|
Telomerase | 1 | 2018 | 746 | 0.030 |
Why?
|
Phosphates | 1 | 1997 | 772 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1697 | 0.030 |
Why?
|
Ubiquitin | 1 | 2018 | 838 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2014 | 392 | 0.030 |
Why?
|
Survival | 1 | 2013 | 161 | 0.030 |
Why?
|
Isoleucine | 1 | 2012 | 110 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2838 | 0.030 |
Why?
|
Hepatocytes | 2 | 2013 | 1229 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5889 | 0.030 |
Why?
|
Pantothenic Acid | 1 | 2011 | 20 | 0.020 |
Why?
|
Lipid Metabolism Disorders | 1 | 2011 | 20 | 0.020 |
Why?
|
Iron Chelating Agents | 1 | 2013 | 138 | 0.020 |
Why?
|
Iron Metabolism Disorders | 1 | 2011 | 24 | 0.020 |
Why?
|
Up-Regulation | 2 | 2015 | 4122 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2014 | 863 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 2 | 2006 | 2471 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2017 | 1674 | 0.020 |
Why?
|
Sphingomyelins | 1 | 2011 | 103 | 0.020 |
Why?
|
Amino Acids, Aromatic | 1 | 2011 | 36 | 0.020 |
Why?
|
Nuclear Respiratory Factors | 2 | 2001 | 18 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3584 | 0.020 |
Why?
|
Leucine | 1 | 2012 | 547 | 0.020 |
Why?
|
Valine | 1 | 2012 | 409 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2013 | 13262 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2016 | 3084 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3301 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 2753 | 0.020 |
Why?
|
Hemoglobins | 1 | 1996 | 1521 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2013 | 13630 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2018 | 9530 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2018 | 1921 | 0.020 |
Why?
|
Hospitalization | 1 | 2010 | 10790 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2013 | 1693 | 0.020 |
Why?
|
Regulon | 1 | 2010 | 71 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2014 | 2262 | 0.020 |
Why?
|
Subcellular Fractions | 1 | 2010 | 532 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1115 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2013 | 682 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1337 | 0.020 |
Why?
|
Adipose Tissue, White | 1 | 2012 | 365 | 0.020 |
Why?
|
Bile Acids and Salts | 1 | 2011 | 382 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10827 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2010 | 389 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
Rhabdomyolysis | 1 | 2010 | 155 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7233 | 0.020 |
Why?
|
Coronary Sinus | 1 | 2008 | 84 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4902 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2014 | 1066 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2008 | 11891 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2015 | 2005 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2013 | 933 | 0.020 |
Why?
|
Cytokines | 1 | 2001 | 7343 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6238 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 2006 | 299 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1754 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2013 | 80372 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2012 | 14495 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15289 | 0.020 |
Why?
|
Partial Pressure | 1 | 2005 | 245 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8158 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 1004 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2012 | 21025 | 0.010 |
Why?
|
Macrophages | 1 | 2019 | 5745 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5253 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2004 | 102 | 0.010 |
Why?
|
Lod Score | 1 | 2005 | 602 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36290 | 0.010 |
Why?
|
Appetite Regulation | 1 | 2004 | 84 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6414 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 2004 | 144 | 0.010 |
Why?
|
Adiposity | 1 | 2014 | 1858 | 0.010 |
Why?
|
Family | 1 | 2014 | 3189 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2004 | 763 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2015 | 3663 | 0.010 |
Why?
|
Genes, p53 | 1 | 2005 | 713 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2005 | 534 | 0.010 |
Why?
|
Acute Kidney Injury | 1 | 2015 | 1941 | 0.010 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2005 | 546 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13502 | 0.010 |
Why?
|
Genes, Recessive | 1 | 2005 | 626 | 0.010 |
Why?
|
Hyperinsulinism | 1 | 2005 | 402 | 0.010 |
Why?
|
Genetic Markers | 1 | 2008 | 2608 | 0.010 |
Why?
|
Inflammation | 2 | 2015 | 10756 | 0.010 |
Why?
|
Body Mass Index | 2 | 2012 | 12914 | 0.010 |
Why?
|
Muscle Weakness | 1 | 2005 | 413 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1996 | 14660 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2004 | 724 | 0.010 |
Why?
|
Arsenates | 1 | 2000 | 10 | 0.010 |
Why?
|
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2000 | 20 | 0.010 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2000 | 71 | 0.010 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2000 | 88 | 0.010 |
Why?
|
Uncoupling Agents | 1 | 2000 | 46 | 0.010 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2001 | 489 | 0.010 |
Why?
|
Lung | 1 | 2018 | 9994 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65017 | 0.010 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2005 | 396 | 0.010 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 1999 | 21 | 0.010 |
Why?
|
NF-E2-Related Factor 1 | 1 | 1999 | 21 | 0.010 |
Why?
|
Biopolymers | 1 | 2000 | 184 | 0.010 |
Why?
|
Massachusetts | 1 | 2012 | 8803 | 0.010 |
Why?
|
Allosteric Regulation | 1 | 2000 | 426 | 0.010 |
Why?
|
Time Factors | 2 | 2013 | 40165 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2007 | 6216 | 0.010 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2001 | 687 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2004 | 1233 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1296 | 0.010 |
Why?
|
3T3 Cells | 1 | 1999 | 1085 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 3215 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2003 | 822 | 0.010 |
Why?
|
Potassium Cyanide | 1 | 1996 | 17 | 0.010 |
Why?
|
Octoxynol | 1 | 1996 | 77 | 0.010 |
Why?
|
Physical Conditioning, Animal | 1 | 2000 | 366 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2005 | 1547 | 0.010 |
Why?
|
User-Computer Interface | 1 | 2003 | 1403 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13314 | 0.010 |
Why?
|
Detergents | 1 | 1996 | 235 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2007 | 3301 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 1999 | 795 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12531 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1628 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2001 | 2209 | 0.010 |
Why?
|
Eating | 1 | 2000 | 1539 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1999 | 1755 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29658 | 0.010 |
Why?
|
United States | 1 | 2020 | 72461 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21392 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25942 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8313 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6360 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2005 | 3602 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1999 | 3380 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6538 | 0.010 |
Why?
|
MicroRNAs | 1 | 2005 | 3790 | 0.000 |
Why?
|
Prospective Studies | 1 | 2011 | 54303 | 0.000 |
Why?
|
Risk Factors | 1 | 2011 | 74359 | 0.000 |
Why?
|